Willow Biosciences (WLLW) Stock Price, News & Analysis

Company Overview

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: C$0.17 to C$0.17
• 52-Week Range: N/A
• Volume: 59,500 shs
• Average Volume: 626,457 shs
• Market Capitalization: C$24.62 million
• P/E Ratio: N/A
• Dividend Yield: 7.35%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:WLLW
• CIK: N/A
• Web: www.willowbio.com
• Phone: 403 910 5140
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$7.92 million
• Net Margins: -23.21%
• Pretax Margin: N/A
• Return on Equity: -9.20%
• Return on Assets: -74.79%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 32.23
• Quick Ratio: 19.71

Sales & Book Value

• Annual Sales: C$2.94 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.83
• Book Value: C$1.13 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 144,847,000
• Free Float: N/A
• Market Cap: C$24.62 million
• Optionable: Not Optionable
• Beta: 1.13